Skip to main content
search

Dr. Marcelo Wood quoted in The Transmitter about future PhD admissions in Neuroscience

Marcelo Wood, PhD, professor and Chair of the department of Neurobiology and Behavior was quoted in The Transmitter about the decrease in admissions to PhD programs in Neuroscience fields including at UCI.  To read the article, click here

Related posts:

  1. FDA delays decision on donanemab The FDA today announced that it will convene an advisory panel to review the data submitted to support potential approval of donanemab, a monoclonal antibody against the beta amyloid protein that demonstrated efficacy in early Alzheimer’s disease in a recent Phase 3 clinical trial. A positive decision to approve donanemab...
  2. LA Times article highlights ARIA A June 17 article in the Los Angeles Times highlighted an important safety risk associated with the new class of medications recently approved for treating Alzheimer’s disease. The drugs are anti-amyloid monoclonal antibodies and include aducanumab, donanemab, and lecanemab. Of these, only lecanemab has achieved full FDA approval at the...
  3. Dr. Leslie Thompson quoted in Science about new insight into Huntington disease Leslie Thompson, PhD, a world renowned scientist and UCI MIND faculty member who studies Huntington disease, was recently quoted in Science about a new landmark paper in Cell. The paper uncovers a more dynamic picture of HTT, the gene responsible for causing the fatal neurodegenerative disease.  To read Dr. Thompson’s...
Close Menu